3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole

Catalog No.: 
ACNGLZ231
CAS No.: 
35179-55-6
Molecular Formula: 
C8H9F3N2
Molecular Weight: 
190.17
3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$64.00In stockInquiry
1g98%$85.00In stockInquiry
5g98%$277.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole
IUPAC Name3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole
MDL No.MFCD01312181
Molecular FormulaC8H9F3N2
Molecular Weight190.17
SMILESFC(F)(F)C1=NNC2=C1CCCC2
InChI KeyKTULFINKQNWXNY-UHFFFAOYSA-N
Synonym1H-Indazole, 4,5,6,7-tetrahydro-3-(trifluoromethyl)-
CAS No.35179-55-6
PubChem CID2802863

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNGLZ231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGLZ231 route product structure diagram
    ACNGLZ23135179-55-6In Stock
Inquiry

2. ACNGLZ231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGLZ231 route product structure diagram
    ACNGLZ23135179-55-6In Stock
Inquiry

3. ACNGLZ231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNGLZ231 route product structure diagram
    ACNGLZ23135179-55-6In Stock
Inquiry

Comments (0)